Omnicell Inc. Stock
Omnicell Inc. Stock
Based on 3 Buy predictions and 2 Sell predictions the sentiment towards Omnicell Inc. is rather balanced.
As a result the target price of 35 € shows a positive potential of 38.89% compared to the current price of 25.2 € for Omnicell Inc..
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | - | -1.563% | -5.970% | -53.761% | -28.000% | -78.824% | -64.844% |
| Integer Hldg | -1.890% | -9.565% | -2.804% | 40.541% | 16.854% | 35.948% | 72.844% |
| Healthequity Inc. | -0.680% | 0.000% | -3.289% | 51.235% | 23.529% | 17.262% | - |
| Bruker Corp. | -9.690% | -4.893% | -16.000% | 1.500% | 9.895% | - | - |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $38.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Benchmark Co. from $42.00 to $38.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $33.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat